Literature DB >> 26349819

Interactions of Klebsiella pneumoniae with the innate immune system vary in relation to clone and resistance phenotype.

Iliana-Maria Pantelidou1, Irene Galani2, Marianna Georgitsi2, George L Daikos3, Evangelos J Giamarellos-Bourboulis2.   

Abstract

Apart from inadequate antimicrobial treatment, specific virulence factors contribute to the high attributable mortality of infections caused by multidrug-resistant (MDR) Klebsiella pneumoniae. We explored the roles of MDR and clones as virulence determinants of K. pneumoniae and their interaction with innate immunity. Twenty isolates were studied and characterized by resistance phenotype and multilocus sequence type (MLST). Human peripheral blood mononuclear cells (PBMCs) were stimulated for the production of proinflammatory cytokines by live and heat-killed isolates and plasmid DNA; modulation by cellular pathway inhibitors was explored. Survival of 30 mice was recorded after intraperitoneal challenge with susceptible and K. pneumoniae carbapenemase (KPC)-producing isolates. Splenocytes of mice were stimulated for the production of pro- and anti-inflammatory cytokines. Isolates were divided into different patterns of production of tumor necrosis factor alpha (TNF-α) and interleukin-1β (IL-1β) poststimulation in relation to both the MLST clone and resistance phenotype. The sequence type 383 (ST383) clone producing Verona integron-encoded metallo-β-lactamase (VIM) stimulated high production of both TNF-α and IL-1β. Clone ST17 producing KPC elicited low TNF-α production; this was reversed by Toll-like receptor 9 (TLR9) antagonists, indicating an effect of plasmid DNA. This isolate was linked with early death of mice compared to high-TNF-α-producing isolates. We conclude that KPC-producing isolates seem to be highly virulent in a low-TNF-α-release environment, suggesting an immunoparalysis induction mechanism. KPC plasmids may directly contribute to the immune system stimulation.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26349819      PMCID: PMC4604363          DOI: 10.1128/AAC.01405-15

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  21 in total

1.  Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates.

Authors:  Laure Diancourt; Virginie Passet; Jan Verhoef; Patrick A D Grimont; Sylvain Brisse
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

2.  Characterization of VIM-2, a carbapenem-hydrolyzing metallo-beta-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France.

Authors:  L Poirel; T Naas; D Nicolas; L Collet; S Bellais; J D Cavallo; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

3.  Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome.

Authors:  Cheol-In Kang; Sung-Han Kim; Wan Beom Park; Ki-Deok Lee; Hong-Bin Kim; Eui-Chong Kim; Myoung-Don Oh; Kang-Won Choe
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

4.  Multidrug resistance to antimicrobials as a predominant factor influencing patient survival.

Authors:  Evangelos J Giamarellos-Bourboulis; Evangelia Papadimitriou; Nearchos Galanakis; Anastasia Antonopoulou; Thomas Tsaganos; Kyriaki Kanellakopoulou; Helen Giamarellou
Journal:  Int J Antimicrob Agents       Date:  2006-05-16       Impact factor: 5.283

Review 5.  Extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory, therapy, and infection control.

Authors:  Enno Stürenburg; Dietrich Mack
Journal:  J Infect       Date:  2003-11       Impact factor: 6.072

6.  Stimulation of innate immunity by susceptible and multidrug-resistant Pseudomonas aeruginosa: an in vitro and in vivo study.

Authors:  E J Giamarellos-Bourboulis; D Plachouras; A Tzivra; V Kousoulas; N Bolanos; M Raftogiannis; I Galani; I Dontas; A Dionyssiou-Asteriou; H Giamarellou
Journal:  Clin Exp Immunol       Date:  2004-02       Impact factor: 4.330

7.  Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York City.

Authors:  Patricia A Bradford; Simona Bratu; Carl Urban; Melissa Visalli; Noriel Mariano; David Landman; James J Rahal; Steven Brooks; Sanda Cebular; John Quale
Journal:  Clin Infect Dis       Date:  2004-06-14       Impact factor: 9.079

8.  Crystals of monosodium urate monohydrate enhance lipopolysaccharide-induced release of interleukin 1 beta by mononuclear cells through a caspase 1-mediated process.

Authors:  E J Giamarellos-Bourboulis; M Mouktaroudi; E Bodar; J van der Ven; B-J Kullberg; M G Netea; J W M van der Meer
Journal:  Ann Rheum Dis       Date:  2008-04-04       Impact factor: 19.103

9.  The impact of multidrug resistance on the pathogenicity of Escherichia coli: an experimental study.

Authors:  Magdalini Bristianou; Charalambos Panagou; Theodoros Adamis; Maria Raftogiannis; Anastasia Antonopoulou; Michael Chrisofos; Irene Galani; Kyriaki Kanellakopoulou; Thomas Tsaganos; Evangelos J Giamarellos-Bourboulis
Journal:  Int J Antimicrob Agents       Date:  2008-01-14       Impact factor: 5.283

10.  Decrease of CD4-lymphocytes and apoptosis of CD14-monocytes are characteristic alterations in sepsis caused by ventilator-associated pneumonia: results from an observational study.

Authors:  Aimilia Pelekanou; Iraklis Tsangaris; Antigoni Kotsaki; Vassiliki Karagianni; Helen Giamarellou; Apostolos Armaganidis; Evangelos J Giamarellos-Bourboulis
Journal:  Crit Care       Date:  2009-11-02       Impact factor: 9.097

View more
  7 in total

1.  Comparison of Septic Shock Due to Multidrug-Resistant Acinetobacter baumannii or Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae in Intensive Care Unit Patients.

Authors:  Alessandro Russo; Simone Giuliano; Giancarlo Ceccarelli; Francesco Alessandri; Alessandra Giordano; Grazia Brunetti; Mario Venditti
Journal:  Antimicrob Agents Chemother       Date:  2018-05-25       Impact factor: 5.191

2.  Comparison of Diabetic and Non-diabetic Human Leukocytic Responses to Different Capsule Types of Klebsiella pneumoniae Responsible for Causing Pyogenic Liver Abscess.

Authors:  I Russel Lee; Ethel Sng; Kok-Onn Lee; James S Molton; Monica Chan; Shirin Kalimuddin; Ezlyn Izharuddin; David C Lye; Sophia Archuleta; Yunn-Hwen Gan
Journal:  Front Cell Infect Microbiol       Date:  2017-09-07       Impact factor: 5.293

Review 3.  The Role of Adjunctive Therapies in Septic Shock by Gram Negative MDR/XDR Infections.

Authors:  Stefano Busani; Erika Roat; Giulia Serafini; Elena Mantovani; Emanuela Biagioni; Massimo Girardis
Journal:  Can J Infect Dis Med Microbiol       Date:  2017-07-09       Impact factor: 2.471

4.  Lipid peroxidation in Gram-negative bacteremia modulates the risk for septic shock and infections by resistant Klebsiella pneumoniae.

Authors:  S Christodoulou; E Kyriazopoulou; M Chrysanthakopoulou; G Karlis; I Karampela; K Gkizeli; N Veliki; A Safarika; E J Giamarellos-Bourboulis; G Adamis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-06-21       Impact factor: 3.267

5.  Reduced Fitness Costs of mcr-1.2 Compared to Mutated pmrB in Isogenic Colistin-Resistant KPC-3-Producing Klebsiella pneumoniae.

Authors:  Cesira Giordano; Adrian Klak; Simona Barnini; Monika A Chlebowicz; Mariacristina Menconi; John W Rossen; Alexander W Friedrich; Erik Bathoorn
Journal:  mSphere       Date:  2019-11-06       Impact factor: 4.389

6.  First Report of bla CTX-M-167, bla SHV-1, and bla TEM-1B Carrying Klebsiella pneumonia Showing High-Level Resistance to Carbapenems.

Authors:  Shirong Li; Siquan Shen; Li Ding; Renru Han; Yan Guo; Dandan Yin; Ming Guan; Fupin Hu
Journal:  Front Microbiol       Date:  2022-07-07       Impact factor: 6.064

7.  Genome-based analysis of Carbapenemase-producing Klebsiella pneumoniae isolates from German hospital patients, 2008-2014.

Authors:  Laura Becker; Martin Kaase; Yvonne Pfeifer; Stephan Fuchs; Annicka Reuss; Anja von Laer; Muna Abu Sin; Miriam Korte-Berwanger; Sören Gatermann; Guido Werner
Journal:  Antimicrob Resist Infect Control       Date:  2018-05-02       Impact factor: 4.887

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.